Your browser doesn't support javascript.
loading
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia.
Steurer, Michael; Montillo, Marco; Scarfò, Lydia; Mauro, Francesca R; Andel, Johannes; Wildner, Sophie; Trentin, Livio; Janssens, Ann; Burgstaller, Sonja; Frömming, Anna; Dümmler, Thomas; Riecke, Kai; Baumann, Matthias; Beyer, Diana; Vauléon, Stéphanie; Ghia, Paolo; Foà, Robin; Caligaris-Cappio, Federico; Gobbi, Marco.
Afiliación
  • Steurer M; Division of Hematology and Oncology, Innsbruck Medical University, Innsbruck, Austria.
  • Montillo M; Department of Hematology, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy.
  • Scarfò L; Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milan, Italy.
  • Mauro FR; Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.
  • Andel J; Medical Dept. 2, County Hospital, Steyr, Austria.
  • Wildner S; Division of Hematology and Oncology, Innsbruck Medical University, Innsbruck, Austria.
  • Trentin L; Department of Medicine, Hematology and Clinical Immunology Branch, University of Padua, Padua, Italy.
  • Janssens A; Department of Hematology, Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
  • Burgstaller S; Department of Internal Medicine IV, Wels-Grieskirchen Hospital, Wels, Austria.
  • Frömming A; NOXXON Pharma, Berlin, Germany.
  • Dümmler T; NOXXON Pharma, Berlin, Germany.
  • Riecke K; current affiliation: Mologen AG, Berlin, Germany and.
  • Baumann M; NOXXON Pharma, Berlin, Germany.
  • Beyer D; NOXXON Pharma, Berlin, Germany.
  • Vauléon S; current affiliation: Mologen AG, Berlin, Germany and.
  • Ghia P; NOXXON Pharma, Berlin, Germany.
  • Foà R; NOXXON Pharma, Berlin, Germany.
  • Caligaris-Cappio F; Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milan, Italy.
  • Gobbi M; Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.
Haematologica ; 104(10): 2053-2060, 2019 10.
Article en En | MEDLINE | ID: mdl-31097627
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2019 Tipo del documento: Article País de afiliación: Austria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2019 Tipo del documento: Article País de afiliación: Austria